It was found that the expression of p65 S276D (a constitutively active form of NF-κB) was associated with a significant increase in the GRO-α promoter activity, while Egr1, CDP had no effect on promoter activity in the context of primary bladder cancer cells (Figure 3D). This evidence concerns the gene CXCL1 and urinary bladder cancer.